US WOMEN WILL DEVELOP INVASIVE BREAST CANCER OVER THE COURSE OF HER LIFETIME.
in EARLY STAGE.
C-Link Micro Imaging Inc. develops flexible Micro Endoscope systems for intraductal imaging (Ductoscopy), which allows for direct visualization on the duct lumen in the breast.
Ductoscopy with the C-Link Micro Endoscope can be performed in the conjunction with a Lumpectomy, allowing the surgeon to achieve clear margins with a minimum of excess tissue removed.
The C-Link Micro Endoscope system is also useful in screening high risk women for early breast cancer detection, and can be performed in the physician’s office as an outpatient. Through direct visualization of the ducts, this approach may allow for breast cancer detection significantly earlier than the mammogram.
C-Link Micro Endoscope system (U.S. FDA Approved, U.S. Patent issued) is designed and manufactured in the U.S.A.
Ductoscopy is an evolving technology that has been used primarily and historically in conjunction with open surgical procedures. New technical improvements allow intraductal biopsy and therefore its application in the clinical setting for diagnostic evaluations of the breast. This study looks at the initial use of intraductal biopsy in a variety of settings from an academic university practice to a private single-surgeon office.
This is a multicenter retrospective series of 88 patients undergoing ductoscopy of ≥1 duct for the diagnostic workup of common breast problems. The procedures were done with the patient under local anesthesia, and intraductal biopsy specimens were taken and analyzed as breast cytology samples.
Of the 88 patients undergoing office ductoscopy, nipple discharge was the most common indication (n = 83 patients; 94% to 66% spontaneous and 34% elicited). Fifty-five percent were high risk for breast cancer by history. The majority of patients had normal previous mammograms: 48 Breast Imaging–Reporting and Data System (BIRADS) 1, 24 BIRADS 2, and 7 BIRADS 3 to 5. The most common finding was papilloma present in 29 (32%) patients by endoscopy. Only 31% of patients had a history of brown or bloody nipple discharge. A wide variety of other endoscopic abnormalities were seen and biopsied. The average number of biopsies per patient was 2 with 18 (20.5%) having severe or malignant atypia. Further follow-up and management of these more concerning abnormalities is currently ongoing.
These results indicate that office ductoscopy with biopsy is both feasible and does identify suspicious or malignant atypia in patients with expressed or spontaneous nipple fluid.
11500 W. Olympic Blvd, Suite 150
Los Angeles, CA 90064, USA
Phone: (310) 854 5800
Fax: (310) 478 7979